Fig. 1: Expression of SH3RF2 in the tumor tissues from DDP-sensitive and DDP-resistant OC patients. | Communications Biology

Fig. 1: Expression of SH3RF2 in the tumor tissues from DDP-sensitive and DDP-resistant OC patients.

From: SH3RF2 contributes to cisplatin resistance in ovarian cancer cells by promoting RBPMS degradation

Fig. 1

a Representative images of IHC staining of SH3RF2 in the tumor tissues from DDP-sensitive and DDP-resistant OC patients (Scale bars, 50 μm). b The quantification of SH3RF2 staining was performed by two pathologists. n = 60. The p values were determined by Mann-Whitney U test.

Back to article page